NAAA and urinary bladder cancer: N-acylethanolamine acid amidase (NAAA), another eCB degrading enzyme, was reported as a promising tool in cancer therapy, as NAAA inhibitors reduced bladder cancer cells proliferation and inhibited migration in vitro [264].